Evangelia Papadimitriou Selected Research

Evangelia Papadimitriou Research Topics

Disease

23	Neoplasms (Cancer) 04/2023 - 01/2002
9	Prostatic Neoplasms (Prostate Cancer) 06/2022 - 10/2005
7	Glioma (Gliomas) 04/2023 - 09/2002
3	Osteoarthritis 01/2023 - 07/2013
3	Neoplasm Metastasis (Metastasis) 06/2022 - 10/2012
2	Necrosis 01/2022 - 08/2009
2	Glioblastoma (Glioblastoma Multiforme) 01/2018 - 01/2009
2	Carcinogenesis 01/2018 - 05/2014
2	Atherosclerosis 01/2016 - 02/2014
1	Neurofibromatosis 1 (Neurofibromatosis Type I) 12/2023
1	Adenocarcinoma of Lung 09/2023
1	Reinjuries 01/2023
1	Arthritis (Polyarthritis) 01/2023
1	Osteosarcoma (Osteogenic Sarcoma) 01/2022
1	Vaccine-Preventable Diseases 01/2020
1	Sarcoma (Soft Tissue Sarcoma) 01/2019
1	Brain Neoplasms (Brain Tumor) 01/2018
1	Malaria 01/2017
1	Breast Neoplasms (Breast Cancer) 01/2017
1	Thrombosis (Thrombus) 12/2016
1	Cardiomegaly (Heart Hypertrophy) 12/2016
1	Hypertrophy 12/2016
1	Congenital Abnormalities (Deformity) 02/2016
1	Hyperplasia 01/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2015
1	Pathologic Neovascularization 12/2014
1	Acne Vulgaris 01/2013
1	Acute Promyelocytic Leukemia 01/2013
1	Crimean Hemorrhagic Fever 03/2011
1	Nervous System Neoplasms (Neoplasms, Nervous System) 12/2009
1	Hemorrhage 01/2009

Drug/Important Bio-Agent (IBA)

19	pleiotrophin (HARP)IBA 06/2022 - 06/2005
14	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2022 - 06/2005
6	Heparin (Liquaemin)FDA LinkGeneric 12/2016 - 06/2005
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 11/2004
5	Class 5 Receptor-Like Protein Tyrosine PhosphatasesIBA 12/2016 - 04/2009
4	NucleolinIBA 06/2022 - 01/2013
4	Proteins (Proteins, Gene)FDA Link 06/2022 - 01/2013
2	Tyrosine (L-Tyrosine)FDA Link 09/2023 - 04/2023
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 09/2023 - 04/2023
2	LigandsIBA 04/2023 - 05/2014
2	Protein Tyrosine PhosphatasesIBA 04/2023 - 08/2014
2	Matrix Metalloproteinases (MMPs)IBA 01/2023 - 01/2022
2	Peptides (Polypeptides)IBA 06/2022 - 08/2009
2	Amino Acids FDA Link 06/2022 - 08/2009
2	IntegrinsIBA 08/2014 - 01/2013
2	RetinoidsIBA 01/2013 - 08/2009
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2013 - 08/2009
1	Vitamin D FDA LinkGeneric 12/2023
1	ineralIBA 12/2023
1	zeta receptorIBA 04/2023
1	Celecoxib (Celebrex)FDA Link 01/2023
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2023
1	Tetracycline (Achromycin)FDA LinkGeneric 01/2022
1	Doxycycline (Periostat)FDA LinkGeneric 01/2022
1	ezrinIBA 01/2022
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 01/2022
1	AntibodiesIBA 01/2020
1	matrigelIBA 01/2019
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2018
1	Anaplastic Lymphoma KinaseIBA 01/2018
1	artemisinin (artemisinine)IBA 01/2017
1	MyogeninIBA 12/2016
1	Simvastatin (Zocor)FDA LinkGeneric 01/2016
1	IvabradineIBA 01/2016
1	ErbB Receptors (EGF Receptor)IBA 10/2015
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 10/2015
1	Epidermal Growth Factor (EGF)IBA 10/2015
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 10/2015
1	Matrix Metalloproteinase 12IBA 09/2015
1	Membrane Proteins (Integral Membrane Proteins)IBA 08/2014
1	betaglycan (TGFBR3)IBA 08/2014
1	Chondroitin Sulfates (Chondroitin Sulfate)IBA 08/2014
1	chondroitin sulfate proteoglycan 4IBA 08/2014
1	SyndecansIBA 08/2014
1	Neuropilin-1IBA 08/2014
1	CholesterolIBA 02/2014
1	retinoic acid receptor betaIBA 01/2013
1	Furocoumarins (Furanocoumarins)IBA 01/2013
1	SpermineIBA 01/2013
1	Retinoic Acid Receptor alphaIBA 01/2013
1	Topoisomerase I InhibitorsIBA 06/2011
1	carbazoleIBA 06/2011
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 06/2011
1	VaccinesIBA 03/2011
1	EstersIBA 08/2009
1	Annexin A5IBA 08/2009
1	Propidium (Propidium Iodide)IBA 08/2009
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2009
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 04/2009
1	Fibrinolysin FDA Link 01/2009
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2009
1	Aprotinin (Trasylol)FDA Link 01/2009
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2008
1	Cisplatin (Platino)FDA LinkGeneric 08/2007

Therapy/Procedure

6	Therapeutics 04/2023 - 11/2004
1	Debridement 01/2023
1	Microspheres (Microsphere) 01/2023
1	Drug Therapy (Chemotherapy) 01/2019
1	Stents 12/2016